GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | Cyp3a9 | affects metabolic processing | ISO | CYP3A5 (Homo sapiens) | 6480464 | CTD | CYP3A5 gene polymorphism affects the metabolism of Tacrolimus; CYP3A5 gene SNP affects the metabolism of Tacrolimus; CYP3A5 protein affects the metabolism of Tacrolimus; CYP3A5 protein polymorphism affects the metabolism of Tacrolimus | PMID:15502717 PMID:15729180 PMID:15808586 PMID:15919447 PMID:15964336 | Cyp3a9 | affects response to substance | ISO | CYP3A5 (Homo sapiens) | 6480464 | CTD | CYP3A5 gene affects the susceptibility to Tacrolimus; CYP3A5 polymorphism affects the susceptibility to Tacrolimus | PMID:15723604 PMID:36931438 | Cyp3a9 | decreases methylation | ISO | CYP3A5 (Homo sapiens) | 6480464 | CTD | CYP3A5 protein results in decreased methylation of Tacrolimus | PMID:15951320 | Cyp3a9 | multiple interactions | ISO | CYP3A5 (Homo sapiens) | 6480464 | CTD | CYP3A5 affects the susceptibility to [Tacrolimus co-treated with Lansoprazole]; CYP3A5 affects the susceptibility to [Tacrolimus co-treated with Rabeprazole]; CYP3A5 gene polymorphism affects the reaction [Ketoconazole results in decreased metabolism of Tacrolimus] | PMID:17377957 PMID:19384264 | |
Go Back to source page | Continue to Ontology report |